Fortrea Holdings Inc.
As of Oct 22, 2026, Fortrea Holdings is in Stage 2, the uptrend phase, now in week 20 (since Jun 5, 2026). It closed at $23.92, at its 52-week high and above its 200-day average, which is rising.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care
Is FTRE early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
FTRE among Biotechnology39th of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …39 | FTRE | Stage 2 · wk 20 | 96 | +22.5% |
Fortrea Holdings: quick answers
What stage is Fortrea Holdings in?
As of Oct 22, 2026, Fortrea Holdings (FTRE) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 5, 2026 and is in week 20. What the four stages mean
Is Fortrea Holdings in an uptrend?
Yes. Fortrea Holdings is in a Stage 2 uptrend. It trades 54.2% above its 200-day average, which is rising.
How far is Fortrea Holdings from its 52-week high?
Fortrea Holdings closed at $23.92 on Oct 22, 2026, at its 52-week high. Its 52-week low is $8.87.
How has Fortrea Holdings performed over the past year?
As of Oct 22, 2026, Fortrea Holdings is up 130.2% over the past year and up 42.3% so far in 2026.
Which sector and industry is Fortrea Holdings in?
Fortrea Holdings is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.